Abstract
This report analyzes the worldwide markets for Artificial Organs in US$
Million. The major product segments analyzed are Artificial Heart, Artificial
Kidneys, Artificial Liver, Artificial Pancreas, and Artificial Lungs. Annual
forecasts are provided for the period of 2003 through 2015. The report
profiles 55 companies including many key and niche players worldwide such as
Abbott Laboratories, Abiomed Inc., Arbios Systems, Inc., Asahi Kasei Kuraray
Medical Co., Ltd., Baxter International, Inc., F. Hoffmann-La Roche Ltd..,
Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care North America,
Inc., Fresenius Kawasumi, Gambro AB, HepaLife Technologies, Inc., Jarvik
Heart, Inc., MC3, Inc., Medtronic, Inc., MicroMed Cardiovascular, Inc.,
Nikkiso Co., Ltd., Nipro Corporation, SynCardia Systems, Inc., Terumo
Corporation, Thoratec Corporation, Toray Medical Co., Ltd., Ventracor Limited,
Vital Therapies, Inc., WorldHeart Corporation, and Xenogenics Corporation.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select
online sources.
View Cart
